P222 Combination of three estrogen receptor α gene polymorphisms associated with knee OA  by unknown
Osteoar thr i t i s  and Cart i lage Vol. 13, Supp lement  A $111 
P221 
POLYMORPHIC VARIANTS IN INTRON 1 OF BMP5 ARE 
ASSOCIATED WITH HIP OSTEOARTHRITIS 
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Background: We have mapped a female-hip OA susceptibility 
locus to chromosome 6 within an interval that encompasses the 
BMP5 gene. This gene codes for the growth factor bone morpho- 
genetic protein 5. BMP5 is expressed in a wide variety of tissues 
of the adult articulating joint (see abstract by Wilkins et al) with 
the BMP5 protein having a critical role in the development and 
maintenance of joint tissues. BMP5 is therefore a logical candi- 
date for OA susceptibility. Our initial analysis of the gene failed to 
detect significant association (P _< 0.05) to BMP5 coding SNPs. 
However, association was detected to microsatellites within non- 
coding and flanking regions of the gene. This data implied that cis 
regulatory elements of BMP5 might code for susceptibility to OA. 
This notion was supported by our observation that a high propor- 
tion of OA patients demonstrate differential allelic expression of 
BMP5 in articular cartilage (Wilkins et al.). 
Aim of study: To conduct a more comprehensive association 
analysis of BMP5 that includes the intronic and flanking se- 
quences of the gene. 
Methods: Twenty-two SNPs and 27 polymorphic microsatellite 
markers from within a 695kb interval of chromosome 6 that en- 
compasses BMP5 and its flanking sequences were genotyped in 
a cohort of unrelated female cases with hip OA and age-matched 
female controls. Alleles, genotypes and haplotypes of the poly- 
morphisms were then tested for association by chi-square analy- 
sis. 
Results: An association was detected to 2 SNPs and an adja- 
cent microsatellite marker located within a 6 kb interval of intron 
1 of BMP5. The two SNPs are in sequence elements that show 
greater than 70% conservation between humans and mice, imply- 
ing that they may have a functional role. The 2 SNPs and the mi- 
crosatellite are in strong to moderate LD (D' > 0.8) and therefore 
appear to be marking the same association. A haplotype analysis 
failed to generate more significant data than the markers alone. 
Conclusions: We have generated evidence to suggest that in- 
tron 1 of BMP5 codes for OA susceptibility in females with hip 
OA. We suspect that effects on the expression of BMP5 may me- 
diate this association. 
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Objective: The association between the polymorphisms in es- 
trogen receptor o~ (ESR1) gene and OA susceptibility has been 
reported but the findings are still controversial. The objective of 
this study was to rationally explain the association with the com- 
bination of several ESR1 SNPs. 
Method: The medical records and DNA samples were obtained 
from 418 unrelated Japanese, 115 non-OA subjects and 303 
symptomatic primary knee OA patients (mean age of 76.2 4- 8.0, 
65 males and 353 females). We genotyped three ESR1 SNPs: 
two well-known intronic SNPs (Pvu II and Xba I) and one synony- 
mous SNP in exon 8. Tibiofemoral joint spaces were measured 
and stratified into quartile according to the scores. The symp- 
tomatic OA patients with radiographic grades of 3 or more were 
included in this study. 
Result: The genotype distributions did not deviate from the HWE, 
but the frequency of Xba I was significantly different from that of 
Caucasians. There found no difference of frequencies between 
OA and non-OA groups in each genotype, allele and the haplo- 
type of these 3 SNPs. Also, the haplotypes or diplotype of Pvu II 
and Xba I could not distinguish these groups. However, consid- 
ering the synonymous SNP genotype with Pvu II - Xba I diplo- 
type, subjects with PpXx diplotype were clearly separated into 
two groups: a risk group and a protective one (PpXx GG(+) group 
vs. PpXx GG(-) group). The distributions of the subjects without 
PpXx genotype were not significantly different and we catego- 
rized them as "the others". The age, BMI, female ratio, duration 
and onset age were not different between these 3 groups. PpXx 
GG(-) genotype had a significantly protective effect (OR = 0.4; 
95% CI: 0.2 to 0.9; p = 0.03). Contrary, PpXx GG(+) genotypes 
were more frequently observed in OA subjects compared to other 
genotype combination (p = 0.04). This tendency was more ap- 
parent in females. We also examined whether the tibiofemoral 
joint space narrowing is associated with these diplotypes. In the 
subjects of PpXx GG(-) group, a significant positive trend was 
observed from the lowest to the highest quartiles of tibiofemoral 
joint space (trend p = 0.0295). This trend was more apparent in 
females (overall p = 0.0368, trend p = 0.0241). 
Conclusion: In our study population, ESR1 Pvu II - Xba I diplo- 
type was essential, but not enough to distinguish the primary 
symptomatic knee OA. By combining with another synonymous 
SNP, we successfully divided risk and protective groups. Further 
investigation of the characteristics of the patients possessing the 
protective genotype could lead a discovering of mechanisms and 
better treatments to protect the patients from progression of the 
disease. 
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Aim of study: To investigate whether small interefering RNA 
(siRNA) suppress the expression of tumor necrosis factor (TNF)- 
and interleukin (IL)-I I~ in synovial fibroblasts of rat in vitro. 
Methods: Four siRNA duplexes specific for TNF-~ or IL-11~ were 
prepared and transduced into cultured peritoneal macrophages 
of rats by the transfection reagents. The expression level of TNF- 
and IL-11~ in supernatant was measured by ELISA after stimu- 
lation with lipopolysaccalide. The most effective siRNA was used 
in the following experiments. Synovial fibroblasts were isolated 
from synovial tissues of knee and ankle joints of collagen induced 
arthritis rats. Alexa-fluor 488 labeled siRNA was transduced into 
synovial fibroblasts by the transfection reagents. The transduced 
cells were observed under fluorescent microscope and the trans- 
duction efficacy was examined. TNF-~ or IL-11~ specific siRNA, 
and negative control siRNA were transduced into cultured syn- 
ovial fibroblast. The total RNA was extracted from these cells. 
The expression levels of TNF-o~ and IL-11~ mRNA were analyzed 
by quantitative real-time PCR. 
Results: All four types of TNF-o~ or IL-11~ specific siRNA 
